Create a free Healthcare Packaging account to continue reading

Nutriband, Kindeva Create New Fentanyl Transdermal System

Kindeva Drug Delivery studies demonstrate Nutriband’s proprietary transdermal aversive coating can be manufactured using standard commercial transdermal manufacturing processes.

Nutriband and Kindeva Drug Delivery have demonstrated enhanced the abuse deterrence kinetics of Aversa™ Fentanyl, an abuse-deterrent fentanyl transdermal system. Studies at Kindeva Drug Delivery have demonstrated that Nutriband’s proprietary transdermal aversive coating can be manufactured using standard commercial transdermal manufacturing processes, which is critical to the success of the product development program. The next step is to select the final product configuration and perform technology transfer from Kindeva’s R&D facility to its world-class transdermal commercial manufacturing site in Northridge, Calif.

AVERSA™ Fentanyl combines Nutriband’s proprietary AVERSA™ abuse-deterrent transdermal technology and Kindeva’s FDA-approved transdermal fentanyl patch (fentanyl transdermal system).

Fill out the form below to request more information about Nutriband, Kindeva Create New Fentanyl Transdermal System